SUPERNUS PHARMACEUTICALS, INC.

SUPN · Nasdaq · SIC 2834: Pharmaceutical Preparations
340
SEC Filings

Business Summary

. Overview Supernus Pharmaceuticals,Inc. (the Company) is a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases. The Company's diverse neuroscience portfolio includes approved treatments for attention-deficit hyperactivity disorder (ADHD), dyskinesia in Parkinson's Disease (PD) patients receiving levodopa-based therapy, hypomobility in PD, postpartum depression (PPD), epilepsy, migraine, cervical dystonia, and ch...

Next Earnings

Q2 FY2026 — expected 2026-08-15

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionSUPNdiscussed_in_filing Cybersecurity
topic_mentionSUPNdiscussed_in_filing Trusted Computing
topic_mentionSUPNdiscussed_in_filing Blockchain & Crypto
topic_mentionSUPNdiscussed_in_filing Regulation
topic_mentionSUPNdiscussed_in_filing Healthcare & Bio
topic_mentionSUPNdiscussed_in_filing Cybersecurity
topic_mentionSUPNdiscussed_in_filing Trusted Computing
topic_mentionSUPNdiscussed_in_filing Blockchain & Crypto
topic_mentionSUPNdiscussed_in_filing Regulation
topic_mentionSUPNdiscussed_in_filing Healthcare & Bio
topic_mentionSUPNdiscussed_in_filing Cybersecurity
topic_mentionSUPNdiscussed_in_filing Trusted Computing
topic_mentionSUPNdiscussed_in_filing Blockchain & Crypto
topic_mentionSUPNdiscussed_in_filing Regulation
topic_mentionSUPNdiscussed_in_filing Healthcare & Bio
topic_mentionSUPNdiscussed_in_filing Cybersecurity
topic_mentionSUPNdiscussed_in_filing Trusted Computing
topic_mentionSUPNdiscussed_in_filing Blockchain & Crypto
topic_mentionSUPNdiscussed_in_filing Regulation
topic_mentionSUPNdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-022025-12-310001356576-26-000011EDGAR109K words
2025-02-252024-12-310001356576-25-000017EDGAR
2024-02-272023-12-310001356576-24-000013EDGAR
2023-03-092022-12-310001356576-23-000016EDGAR
2022-04-132021-12-310001356576-22-000025EDGAR
2021-03-082020-12-310001356576-21-000028EDGAR
2020-02-282019-12-310001356576-20-000010EDGAR
2019-03-012018-12-310001047469-19-000828EDGAR
2018-03-012017-12-310001047469-18-001210EDGAR
2017-03-162016-12-310001047469-17-001684EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001356576-25-000071EDGAR42K words
2025-08-052025-06-300001356576-25-000055EDGAR
2025-05-062025-03-310001356576-25-000033EDGAR
2024-11-042024-09-300001356576-24-000067EDGAR
2024-08-062024-06-300001356576-24-000051EDGAR
2024-05-082024-03-310001356576-24-000028EDGAR
2023-11-082023-09-300001356576-23-000072EDGAR
2023-08-082023-06-300001356576-23-000050EDGAR
2023-05-092023-03-310001356576-23-000034EDGAR
2022-11-092022-09-300001356576-22-000076EDGAR
2022-08-082022-06-300001356576-22-000057EDGAR
2022-05-122022-03-310001356576-22-000046EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-240001356576-26-000007EDGAR1K words
2026-02-240001356576-26-000004EDGAR
2026-02-120001356576-26-000002EDGAR
2026-01-280001628280-26-003907EDGAR
2025-11-040001356576-25-000068EDGAR
2025-10-210001356576-25-000065EDGAR
2025-08-050001356576-25-000053EDGAR
2025-08-040001356576-25-000050EDGAR
2025-07-310001104659-25-072506EDGAR
2025-07-220001356576-25-000046EDGAR

340 total filings indexed. 308 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001356576
TickerSUPN
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: d2b8c8af28bd42ceee08fb76644576431d7498f0e37dc5764af739f6e42ef6fc
parent: 874845f23b5a7b4db1e15e766793d69fbd2cc00980fa1c4f873706b4be57822a
content hash: a100395b5aaca50e37db44c89ea97c3a950f556f4e07b496a7e9549a17e41eda
signed: 2026-04-13T04:47:40.202Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf